timonensis (SP2-71.3) produced TMA in the absence of molecular oxygen, suggesting a novel microbial pathway for l-carnitine catabolism independent of the CntA/B oxygenase (25, 26)
As of February 18, 2026, the class has expanded with established agents like semaglutide, liraglutide, dulaglutide, and exenatide, alongside dual GLP-1/GIP agonists such as tirzepatide, which are often discussed in GLP-1 contexts due to overlapping mechanisms and indications
The development of orforglipron, a small molecule (non-peptide) oral GLP-1 receptor agonist by Eli Lilly, introduces a paradigm-shifting consideration
Keep Refrigerated
However, carnitine fortification is not "the more, the better"
This powerful antioxidant is essential for various bodily functions, including detoxification, immune system support, and maintaining the health of vital organs like the liver and kidneys